About the Authors
- D. Mouttet
-
Affiliation Department of Surgery, Institut Curie, Paris, France
- M. Laé
-
Affiliation Department of Tumor Biology, Institut Curie, Paris, France
- M. Caly
-
Affiliation Department of Tumor Biology, Institut Curie, Paris, France
- D. Gentien
-
Affiliation Department of Translational Research, Institut Curie, Paris, France
- S. Carpentier
-
Affiliation QIAGEN Marseille SA, Marseille, France
- H. Peyro-Saint-Paul
-
Affiliation QIAGEN Marseille SA, Marseille, France
- A. Vincent-Salomon
-
Affiliation Department of Tumor Biology, Institut Curie, Paris, France
- R. Rouzier
-
Affiliation Department of Surgery, Institut Curie, Paris, France
- B. Sigal-Zafrani
-
Affiliation Department of Tumor Biology, Institut Curie, Paris, France
- X. Sastre-Garau
-
Affiliation Department of Tumor Biology, Institut Curie, Paris, France
- F. Reyal
-
* E-mail: fabien.reyal@curie.fr
Affiliations Department of Surgery, Institut Curie, Paris, France, Residual Tumor and Response to Treatment Team, Institut Curie, Department of Translational Research, Paris, France
Competing Interests
SC and HP are employees of the commercial company QIAGEN. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide of authors.
Author Contributions
Conceived and designed the experiments: DM FR XS. Performed the experiments: DM FR XS. Analyzed the data: FR XS. Contributed reagents/materials/analysis tools: FR XS ML. Wrote the paper: DM FR ML AV RR BS DG MC. Full-time employees of QIAGEN Marseille, funder of the project: SC HP.